We are very pleased to announce that 300K has been granted with €50,000 from Horizon 2020 SME Instrument Phase I for our submission of “Biotem” project. 300K has satisfied the requirements in order to perform a feasibility study to verify the technological, practical and economic viability of our disruptive solution.
The project will emphazise on validation of the market, technical and financial feasibility analysis of legal and IP aspects and partner search. Here you can find an overview of the activities as follows:
Validation of market feasibility, will be focused on collecting valuable feedback through user involvement, stakeholders and contacting international distributors.
Validation of technical feasibility, current prototypes and complementary products will be subject to further modifications for usability, robustness and reliability improvements.
Analysis of IP and legal/regulatory, the work will be focused on continuous management of IP mainly related to complementary products or coming from new requirements identified on the aforementioned tasks.
Partner search, will be focused on identifying, contacting and selecting key partners for the implementation of the next phases of the project, including suppliers of OEM products and components, manufacturing/quality control subcontractors and international distributors.
Validation of economic feasibility, a detailed economic analysis will be performed to update the current financial data. Refined estimation of key indicators such as return on investment, profit, payback of investment or market size will allow to assess the economic viability of the overall project and quantify the funding needs in order to achieve successful commercialization of the solution.
For more information about Horizon 2020 and Biotem project we suggest that you visit:
"Biotem" Innovative solution for maintenance and storage of Biospecimens at Room Temperature
“This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 866688”.